Skip to main content
Year archive

SAM CHUN DANG PHARM CO. LTD — 2023 filings

All 32 regulatory filings released by SAM CHUN DANG PHARM CO. LTD (000250) in 2023, sourced directly from the official regulator.

32 Filings
2023 Period
2023 filings (32)
Filing Released Lang
[기재정정]단일판매ㆍ공급계약체결(자율공시)
Capital/Financing Update
2023-12-28 Korean
현금ㆍ현물배당을위한주주명부폐쇄(기준일)결정
Notice of Dividend Amount
2023-12-15 Korean
주주명부폐쇄기간또는기준일설정
Notice of Dividend Amount
2023-12-15 Korean
[기재정정]단일판매ㆍ공급계약체결(자율공시)
Regulatory Filings
2023-11-30 Korean
투자판단관련주요경영사항(SCD411(아일리아 바이오시밀러) VIAL 및 PFS(Pre-filled Syringe) 한국 품목허가 신청)
Regulatory Filings
2023-11-30 Korean
투자판단관련주요경영사항(황반변성치료제(아일리아/주성분 : Aflibercept) 바이오시밀러 SCD411(Vial&PFS)의 유럽 5개국(독일, 스페인, 이태리, 스위스, 오스트리아) 독점판매권 및 공급계약 체결)
Regulatory Filings
2023-11-20 Korean
분기보고서 (2023.09)
Interim / Quarterly Report 9M 2023
2023-11-14 Korean
풍문또는보도에대한해명(미확정)
Regulatory Filings
2023-10-27 Korean
[기재정정]수시공시의무관련사항(공정공시)(아일리아 바이오시밀러(SCD411) Binding Term Sheet 체결)
M&A Activity
2023-09-27 Korean
전환청구권행사
Share Issue/Capital Change
2023-08-31 Korean
투자판단관련주요경영사항(황반변성치료제(아일리아/주성분 : Aflibercept) 바이오시밀러 SCD411(Vial&PFS)의 캐나다 독점판매권 및 공급계약 체결)
M&A Activity
2023-08-23 Korean
반기보고서 (2023.06)
Interim / Quarterly Report H1 2023
2023-08-14 Korean
풍문또는보도에대한해명(미확정)
Regulatory Filings
2023-07-28 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification
2023-07-10 Korean
[기재정정]수시공시의무관련사항(공정공시)(아일리아 바이오시밀러(SCD411) Binding Term Sheet 체결)
M&A Activity
2023-07-03 Korean
[기재정정]단일판매ㆍ공급계약체결(자율공시)
Regulatory Filings
2023-06-30 Korean
분기보고서 (2023.03)
Interim / Quarterly Report Q1 2023
2023-05-15 Korean
[기재정정]수시공시의무관련사항(공정공시)(아일리아 바이오시밀러(SCD411) Binding Term Sheet 체결)
M&A Activity
2023-05-04 Korean
풍문또는보도에대한해명(미확정)
Regulatory Filings
2023-04-28 Korean
풍문또는보도에대한해명(미확정)
Regulatory Filings
2023-03-31 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2023-03-29 Korean
전환청구권행사
Share Issue/Capital Change
2023-03-28 Korean
[기재정정]전환청구권행사
Share Issue/Capital Change
2023-03-28 Korean
[기재정정]전환청구권행사
Share Issue/Capital Change
2023-03-28 Korean
투자판단관련주요경영사항(아일리아 바이오시밀러(SCD411) 임상 3상 결과 발표)
Regulatory Filings
2023-03-24 Korean
감사보고서제출
Audit Report / Information FY 2022
2023-03-21 Korean
사업보고서 (2022.12)
Annual Report FY 2022
2023-03-21 Korean
주주총회소집공고
AGM Information
2023-03-10 Korean
주주총회소집결의
AGM Information
2023-02-28 Korean
[기재정정]수시공시의무관련사항(공정공시)(아일리아 바이오시밀러(SCD411) Binding Term Sheet 체결)
M&A Activity
2023-02-23 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release FY 2022
2023-02-10 Korean
풍문또는보도에대한해명(미확정)
Regulatory Filings
2023-02-03 Korean